125 related articles for article (PubMed ID: 12619540)
1. Radiation therapy in the management of early-stage head and neck cancer.
Hinerman RW; Mendenhall WM; Amdur RJ
Cancer Treat Res; 2003; 114():115-44. PubMed ID: 12619540
[No Abstract] [Full Text] [Related]
2. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck.
Mendenhall WM; Parsons JT
Cancer Invest; 1998; 16(8):594-603. PubMed ID: 9844620
[TBL] [Abstract][Full Text] [Related]
3. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner?
Bentzen SM; Dische S
Radiother Oncol; 1999 May; 51(2):105-7. PubMed ID: 10435799
[No Abstract] [Full Text] [Related]
4. Confirmation of improved local-regional control with altered fractionation in head and neck cancer.
Fowler JF; Harari PM
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):3-6. PubMed ID: 10924965
[No Abstract] [Full Text] [Related]
5. Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas.
De Crevoisier R; Bourhis J; Eschwège F
Cancer Treat Res; 2003; 114():199-212. PubMed ID: 12619542
[No Abstract] [Full Text] [Related]
6. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
Bentzen SM; Bernier J
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
[No Abstract] [Full Text] [Related]
7. [Not Available].
Klages HT
Strahlenther Onkol; 2014 Oct; 190(10):970-2. PubMed ID: 25392873
[No Abstract] [Full Text] [Related]
8. [Radiation therapy for head and neck cancer].
Mitsuhashi N; Akimoto T; Hayakawa K; Muramatsu H; Niibe H
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jan; 61(1):10-6. PubMed ID: 11218740
[TBL] [Abstract][Full Text] [Related]
9. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
Dubben HH; Beck-Bornholdt HP
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
[No Abstract] [Full Text] [Related]
10. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
Poddar J; Sharma AD; Kunikullaya SU; Neema JP
Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
[TBL] [Abstract][Full Text] [Related]
11. How to optimize therapeutic ratio in brachytherapy of head and neck squamous cell carcinoma?
Mazeron JJ; Gerbaulet A; Simon JM; Hardiman C
Acta Oncol; 1998; 37(6):583-91. PubMed ID: 9860317
[TBL] [Abstract][Full Text] [Related]
12. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
13. The management of head and neck tumors with high technology radiation therapy.
Mendez LC; Moraes FY; Poon I; Marta GN
Expert Rev Anticancer Ther; 2016; 16(1):99-110. PubMed ID: 26568146
[TBL] [Abstract][Full Text] [Related]
14. Absence of cervical radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck.
Jeremic B; Shibamoto Y; Igrutinovic I
J Cancer Res Clin Oncol; 2001 Nov; 127(11):687-91. PubMed ID: 11710599
[TBL] [Abstract][Full Text] [Related]
15. A case-control study of patients with squamous cell carcinoma of the oral cavity and oropharynx treated with pulsed-dose-rate brachytherapy.
Haddad A; Peiffert D; Lapeyre M; Harter V; Buchheit I; Graff P
Brachytherapy; 2014; 13(6):597-602. PubMed ID: 24913434
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy for advanced head and neck squamous-cell carcinoma using twice-a-day fractionation.
Medini E; Rao Y; Kim T; Jones TK; Levitt SH
Radiology; 1980 Feb; 134(2):531-2. PubMed ID: 7352244
[TBL] [Abstract][Full Text] [Related]
17. Cancer of the pyriform fossa: hyperfractionated radiotherapy as a primary treatment modality.
Conlon BJ; Walsh M; McShane D; Corcoran N; Moriarty M; Healy JB; Fraser I; O'Dwyer TP
Clin Otolaryngol Allied Sci; 1997 Aug; 22(4):327-31. PubMed ID: 9298607
[TBL] [Abstract][Full Text] [Related]
18. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
20. Treatment of head and neck cancer with CHART and nimorazole: phase II study.
Henk JM; Bishop K; Shepherd SF
Radiother Oncol; 2003 Jan; 66(1):65-70. PubMed ID: 12559522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
